| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in DMRA over the last quarter tilts toward buying: insiders added a net 12,500 shares worth roughly $253K.
DMRA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 512.5K | $10.37M | - | |
| COO | 190.4K | - | - | |
| Dir | 37.3K | - | - | |
| Dir | 37.3K | - | - | |
| 10% | 37.3K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Jarrett Jennifer74 | Director, President And CEO | Buy | 12,500 | $20.23 | $252,875.00 | +2.5% | - | - | |
| Jul 6, 2026 | Winslow Garrett | General Counsel | Sale+OE | 245 | $29.98 | $7,345.10 | -9.7% | -32.1% | - |